Kim Peter S's Form 4/A amendment
AmendedEntrada Therapeutics, Inc. (TRDA) · filed Jun 18, 2025
- Accession no.
- 0001689375-25-000035
- Filed
- Jun 18, 2025
- Trade date
- May 13-14, 2024
- Filing delay
- 401 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- May 16, 2024
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $731.8K. It was filed 401 days after the trade.
This amendment replaces 0001689375-24-000029 (filed May 16, 2024).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kim Peter SCIK 0001181180 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 13, 2024 | Common Stock | PPurchaseAcquired | +25,000 | $14.68 | +$367,000 | 92,412 | Direct | |
| May 14, 2024 | Common Stock | PPurchaseAcquired | +25,000 | $14.59 | +$364,750 | 117,412 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.